Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.38 |
| ▸ | GRM2 | Q14416 | 3/20 | 0.38 |
| ▸ | GRM3 | Q14832 | 3/20 | 0.38 |
| ▸ | NSD2 | O96028 | 1/20 | 0.38 |
| ▸ | ARG1 | P05089 | 2/20 | 0.37 |
| ▸ | GRM4 | Q14833 | 8/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | GRM8 | O00222 | 2/20 | 0.35 |
| ▸ | GRM6 | O15303 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19575870 | 1.00 | CYP1A2 (0.38) | CYP1A2ALOX15GRM2GRM3NSD2 | |
| SCHEMBL29956680 | 0.86 | — | — | |
| SCHEMBL28595938 | 0.86 | — | — | |
| SCHEMBL1433577 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL25279878 | 0.84 | GRM4 (0.41) | CYP1A2ALOX15GRM2GRM3NSD2 | |
| Hydrochloric Acid SCHEMBL28913901 | 0.84 | GRM4 (0.41) | CYP1A2ALOX15GRM2GRM3NSD2 | |
| Hydrochloric Acid SCHEMBL28913902 | 0.84 | GRM4 (0.41) | CYP1A2ALOX15GRM2GRM3NSD2 | |
| SCHEMBL22481368 | 0.83 | KDM4E (0.35) | KMT2ACYP2D6KDM4E | |
| SCHEMBL22519410 | 0.77 | CYP1A2 (0.37) | CYP1A2ALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL23866631 | 0.77 | CYP1A2 (0.37) | CYP1A2ALDH1A1MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12576169-B2 | Silicon-fluoride acceptor substituted radiopharmaceuticals and precursors thereof | Technische Universität München (DE) | 2026-03-17 | — | — | US | claimed |
| US-20220096669-A1 | SILICON-FLUORIDE ACCEPTOR SUBSTITUTED RADIOPHARMACEUTICALS AND PRECURSORS THEREOF | Technische Universität München (DE) | 2022-03-31 | — | — | US | claimed |
| EP-3917581-A1 | SILICON-FLUORIDE ACCEPTOR SUBSTITUTED RADIOPHARMACEUTICALS AND PRECURSORS THEREOF | Technische Universität München (DE) | 2021-12-08 | — | — | EP | claimed |
| CN-113677375-A | Fluorinated silicon receptor substituted radiopharmaceuticals and precursors thereof | 慕尼黑工业大学 | 2021-11-19 | — | — | CN | claimed |
| WO-2020157128-A1 | SILICON-FLUORIDE ACCEPTOR SUBSTITUTED RADIOPHARMACEUTICALS AND PRECURSORS THEREOF | Technische Universität München (DE) | 2020-08-06 | — | — | WO | claimed |
| WO-2015065916-A1 | ANTI MICROBIAL PEPTIDES INCORPORATING CYCLIC ALPHA TETRA-SUBSTITUTED UNNATURAL AMINO ACIDS | EAST CAROLINA UNIVERSITY (US) | 2015-05-07 | — | — | WO | claimed |
| US-8188033-B2 | Anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity | USA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF USAMRMC | 2012-05-29 | — | — | US | claimed |
| US-20090291898-A1 | Novel anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity | USA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF USAMRMC | 2009-11-26 | — | — | US | claimed |
| EP-2120983-A2 | NOVEL ANTI-MICROBIAL PEPTIDOMIMETIC COMPOUNDS AND METHODS TO CALCULATE ANTI-MICROBIAL ACTIVITY | The United States of America, as represented by The Secretary of the Army, on behalf of The Walter Reed Army Institute of Research (US) | 2009-11-25 | — | — | EP | claimed |
| WO-2008079314-A2 | NOVEL ANTI-MICROBIAL PEPTIDOMIMETIC COMPOUNDS AND METHODS TO CALCULATE ANTI-MICROBIAL ACTIVITY | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY, ON BEHALF OF WALTER REED ARMY INSTITUTE OF RESEARCH (US) | 2008-07-03 | — | — | WO | claimed |
| EP-4727653-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4727654-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4729094-A2 | Modulators of complement activity | UCB Holdings, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4727655-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-12576169-B2 | Silicon-fluoride acceptor substituted radiopharmaceuticals and precursors thereof | Technische Universität München (DE) | 2026-03-17 | — | — | US | disclosed |
| US-20120197004-A1 | NOVEL ANTI-MICROBIAL PEPTIDOMIMETIC COMPOUNDS AND METHODS TO CALCULATE ANTI-MICROBIAL ACTIVITY | HICKS RICKEY P (US) | 2012-08-02 | — | — | US | disclosed |
| US-8188033-B2 | Anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity | USA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF USAMRMC | 2012-05-29 | — | — | US | disclosed |
| US-20090291898-A1 | Novel anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity | USA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF USAMRMC | 2009-11-26 | — | — | US | disclosed |
| EP-2120983-A2 | NOVEL ANTI-MICROBIAL PEPTIDOMIMETIC COMPOUNDS AND METHODS TO CALCULATE ANTI-MICROBIAL ACTIVITY | The United States of America, as represented by The Secretary of the Army, on behalf of The Walter Reed Army Institute of Research (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008079314-A2 | NOVEL ANTI-MICROBIAL PEPTIDOMIMETIC COMPOUNDS AND METHODS TO CALCULATE ANTI-MICROBIAL ACTIVITY | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY, ON BEHALF OF WALTER REED ARMY INSTITUTE OF RESEARCH (US) | 2008-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220096669-A1 | SILICON-FLUORIDE ACCEPTOR SUBSTITUTED RADIOPHARMACEUTICALS AND PRECURSORS THEREOF | FOLH1, KLK3, FRS2 | CYP1A2 4670/4885ALOX15 4760/4885GRM2 2081/4885 |
| US-12576169-B2 | Silicon-fluoride acceptor substituted radiopharmaceuticals and precursors thereof | KLK3, FOLH1, SLC7A1 | CYP1A2 4726/4885ALOX15 4816/4885GRM2 959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.